You are here: Reports and briefings Reports and briefings Investing In Malaria - A Pathway To Greater Pandemic Prevention, Preparedness And Response Securing Britain's Future: How investments in ending malaria strengthen the UK economy, life sciences sector and NHS Our Impact Report 2024 The case for investing in the Global Fund to fight AIDS, tuberculosis and malaria in 2025 Britain's Golden Opportunity The Malaria Dividend Our Impact Report 2023 Britain and Beyond: Achieving a stronger, safer world through malaria eradication Commonwealth Health Ministers' Briefing World Malaria Report 2022 Britain at its best: Delivering opportunity for women and girls through malaria eradication World Malaria Report 2021 Best of British: How British-backed science can accelerate the end of malaria Commonwealth Malaria Report 2021 Leave No Fever Unresolved: Malaria and global health security World Malaria Report 2020 Commonwealth Malaria Report 2019 Malaria Futures for Asia (MalaFAsia) Report Bridging the gaps in malaria R&D Ready to Beat Malaria 2018: Summit Commitments Malaria Futures for Africa (MalaFA) Report Phenomenal progress: The UK’s pivotal role in turning the tide against malaria Global Britain and ending malaria: The bottom line Financing for impact: Meeting milestone malaria targets through innovation and collaboration The Commonwealth and malaria: why we need to act now Investing for a malaria-free world Malaria: Bad for Business - Why investing in ending malaria provides some of the highest economic returns
Securing Britain's Future: How investments in ending malaria strengthen the UK economy, life sciences sector and NHS
Malaria: Bad for Business - Why investing in ending malaria provides some of the highest economic returns